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Reverse genetic systems were developed for a highly virulent datypicalT porcine reproductive and respiratory syndrome virus (PRRSV).
The full-length genome of 15395 nucleotides was assembled as a single cDNA clone and placed under either the prokaryotic T7 or eukaryotic
CMV promoter. Transfection of cells with the RNA transcripts or the DNA clone induced cytopathic effects and produced infectious progeny.
The reconstituted virus was stable and grew to the titer of the parental virus in cells. Upon infection, pigs produced clinical signs and lung
pathology typical for PRRSV and induced viremia and specific antibodies. Previously, we showed that the PRRSV nucleocapsid (N) protein
forms homodimers via both noncovalent and covalent interactions and that cysteine at position 23 is responsible for the covalent interaction.
The functional significance of cysteines of N for PRRSV infectivity was assessed using the infectious cDNA clone. Each cysteine of N at
positions 23, 75, and 90 was replaced with serine and the individual mutation was incorporated into the cDNA clone such that three
independent cysteine mutants were constructed. When transfected, the wild type and C75S clones induced cytopathic effects and produced
infectious virus with indistinguishable plaque morphology. In contrast, the C23S mutation completely abolished infectivity of the clone,
indicating that C23-mediated N protein homodimerization plays a critical role in PRRSV infectivity. Unexpectedly, the C90S mutation also
appeared to be lethal for virus infectivity. Genome replication and mRNA transcription were both positive for the replication-defective C23S
and C90S mutants. The data suggest that, in addition to homodimerization, the PRRSV N protein may also undergo heterodimerization with
another structural protein using cysteine 90 and that the N protein heterodimerization is essential for PRRSV infectivity.
D 2004 Elsevier Inc. All rights reserved.
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Porcine reproductive and respiratory syndrome (PRRS)
is an emerging disease in swine and considered the single
most economically important disease of pigs worldwide.
The disease was first recognized in North America in 1987
(Keffaber, 1989) and in 1990 in Europe; and subsequently,
the PRRS virus (PRRSV) was isolated as the causative
agent in The Netherlands (Wensvoort et al., 1991) and in
the USA (Benfield et al., 1992). PRRSV is an enveloped,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: dyoo@uoguelph.ca (D. Yoo).single-stranded, positive-sense RNA virus belonging to the
family Arteriviridae, which forms the order Nidovirales
together with the Coronaviridae family (Cavanagh, 1997;
Meulenberg et al., 1993). The PRRSV genome is
approximately 15 kb in size and is enclosed in the
isomeric capsid structure (Meulenberg et al., 1993; Snijder
and Meulenberg, 1998; Wootton et al., 2000). The viral
genome contains nine open reading frames (ORFs),
designated ORF1a, ORF1b, ORF2a, ORF2b, and ORFs 3
through 7, in order from the 5V end of the genome
(Meulenberg et al., 1993; Snijder and Meulenberg, 1998;
Wootton et al., 2000). ORF1a and ORF1b code for 1a and
1a/1b polyproteins by ribosomal frame shifting, and these005) 47–62
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RNA. The polyproteins are believed to be cleaved into 13
nonstructural proteins (nsp) that then participate in genome
replication and transcription (Bautista et al., 2002; van
Dinten et al., 1999). ORFs 2a through 7 code for the
structural proteins GP2a, 2b (E), GP3, GP4, GP5,
membrane (M) protein, and nucleocapsid (N) protein,
respectively. These structural proteins are translated from a
nested set of 3V-coterminal subgenomic mRNAs (Meulen-
berg et al., 1995; Snijder and Meulenberg, 1998; Wu et al.,
2001).
PRRSV is divided into two distinct types, the European
and North American types, and these types show significant
genetic and antigenic differences with an overall sequence
identity of only 63% (Meng et al., 1995; Nelsen et al., 1999;
Nelson et al., 1993; Wensvoort et al., 1991; Wootton et al.,
2000). The N protein of PRRSV is a multifunctional
protein. It is comprised of 123 or 128 amino acids for the
North American and European types, respectively. The N
protein is highly immunogenic in pigs, and major epitopes
are predominantly located in the central region of the
protein (Rodriguez et al., 1997; Wootton et al., 1998).
Mutational analysis revealed that the carboxyl-terminus of
N plays a critical role for maintaining the overall
conformation of the protein (Meulenberg et al., 1998a;
Wootton et al., 1998, 2001). The N protein is a basic protein
with an isoelectric point of 10.4 and was shown to be a
serine phosphoprotein (Wootton et al., 2002). As with many
other RNA viruses, PRRSV replication occurs in the
cytoplasm, and accordingly, the N protein is largely
distributed in the perinuclear region of infected cells.
Recently, the N protein has been found to localize to the
nucleus and nucleolus (Rowland et al., 1999), and the
stretch of basic amino acids at positions 41–47 has been
identified as a functional nuclear localization signal (NLS).
In the nucleus, the N protein colocalizes and interacts with
the small nucleolar RNA-associated protein fibrillarin (Yoo
et al., 2003), which implicates nonstructural involvement of
N in ribosome biogenesis. As the structural component of
viral capsid, the PRRSV N protein interacts with itself by
both covalent and noncovalent interactions. Upon trans-
lation in the cytoplasm, the N protein interacts with itself via
noncovalent binding. As N is transported to the lumen of
the endoplasmic reticulum (ER) and the Golgi complex,
where its environment is oxidative and PRRSV maturation
occurs, the N–N interaction becomes disulfide linked. The
disulfide-linked homodimeric N protein is then assembled
to viral capsids (Snijder and Meulenberg, 1998; Wootton
and Yoo, 2003).
North American PRRSV N proteins contain three
conserved cysteine residues at amino acid positions 23,
75, and 90, and by mutational analysis using the expressed
protein, cysteine at position 23 has been shown to be
responsible for disulfide-linked N–N interactions in vitro
(Wootton and Yoo, 2003). Conservation of cysteine
residues, however, is highly divergent in N proteins amongarteriviruses. The N proteins of European PRRSV and
lactate dehydrogenase elevating virus (LDV) contain only
two cysteine residues at different positions (Kuo et al.,
1991; Meulenberg et al., 1993), and even further, equine
arteritis virus (EAV) and simian hemorrhagic fever virus
(SHFV) completely lack cysteines in their N protein (den
Boon et al., 1991; Godeny et al., 1995). Thus, the bio-
logical significance of arterivirus N protein dimerization is
questionable.
Investigation of such in vivo interactions requires a
molecular tool for reverse genetics, so that an RNA genome
can be precisely manipulated to allow a specific modifica-
tion at a targeted site. In the present study, we describe a
reverse genetics system for a North American PRRSV
isolate and apply the system to investigate the biological
relevance of homodimerization of N. Individual cysteines of
the N protein were mutated at the DNA level, and three
independent genomic cDNA clones were constructed. The
role of the N protein dimerization for virus infectivity was
then investigated in vivo using the reconstructed genomic
clones, and we report here that the cysteine-mediated
homodimerization of N plays a fundamental role in PRRSV
assembly and infectivity. Our data also suggest a possible
additional involvement of the N protein for heterodimeriza-
tion with another protein of the virus.Results
Cloning and sequencing of the full-length genomic RNA of
the P129 virus
The full-length genomic sequence of the North Amer-
ican PRRSV isolate P129 was first determined. Over-
lapping cDNA fragments were generated by RT-PCR using
various PCR primers (Table 1), designed based on
available sequences for other North American PRRSV
isolates. Each PCR product was cloned and sequenced in
both directions. The 5V and 3V terminal sequences of the
viral genome were determined by 5V rapid amplification of
cDNA ends (RACE) and by RT-PCR across the junction of
circularized viral RNA, respectively. All regions of the
genome were sequenced with at least 3-fold redundancy
using cloned products from independent RT-PCR reactions.
This allowed assembly of an accurate consensus sequence
for the virus. Nearly all of the individual PCR products
deviated from the consensus by at least one base
substitution. This variation appears to be largely due to
the quasispecies nature of PRRSV, but may also include a
component of PCR-induced mutation. To minimize possi-
ble introduction of lethal mutations in future constructs,
individual PCR fragments were repaired by subcloning the
corresponding subfragments from other PCR reactions.
Two specific mutations, C to T at nucleotide position 1559
of the genome and A to G at position 12622, were not
corrected and were retained as genetic markers for the
Table 1
Primers used for RT-PCR to synthesize four overlapping cDNA clones for P129 virus
Primer name Nucleotide sequence Location within P129 genome
Fragment 1756
RACE2 Rev () 5V-CCGGGGAAGCCAGACGATTGAA-3V 1917–1938
RACE3 Rev () 5V-AGGGGGAGCAAAGAAGGGGTCATC-3V 1733–1756
Fragment 8078
Fwd8078 (+) 5V-AGCACGCTCTCGTGCAACTG-3V 1361–1380
Rev8078 () 5V-GCCGCGGCGTAGTATTCAG-3V 9420–9438
Fragment 2850
Fwd2850 (+) 5V-ACCTCGTGCTGTATGCCGAATCTC-3V 9201–9224
Rev2850 () 5V-TCAGGCCTAAAGTTGGTTCAATGA-3V 12,027–12,050
Fragment 3892
Fwd3892 (+) 5V-ACTCAGTCTAAGTGCTGGAAAGTTATG-3V 11,504–11,530
Rev3892 () 5V-GGGATTTAAATATGCAT21AATTGCGGCCGCATGGTTCTCG-3V 15,374–15,395
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in nsp2 while the A12622G mutation results in substitution
of arginine for glutamine at amino acid position 189 of
GP2a.
The overlapping sequences were assembled into a
single sequence. The genome of the P129 virus was
determined to be 15395 nucleotides, excluding the
polyadenosine tail of typically 50–70 adenosines. The 5V
UTR (the leader) of P129 is 191 nucleotides in length; two
bases longer than the corresponding leaders of North
American prototype isolate VR-2332 (Nelsen et al., 1999;
Nielsen et al., 2003) and Canadian isolate PA-8 (Wootton
et al., 2000). An adenosine residue was identified at the
extreme 5V end of PRRSV P129, and this residue is
designated position 1 of the full-length PRRSV cDNA
clone (Fig. 1A). The leader-body junction sequence
(UUAACC) at the 3Vend of the leader is identical to those
from North American and European isolates. Two large
overlapping ORFs, la and lb (of 7494 and 4392
nucleotides, respectively), follow the 5V UTR. Six addi-
tional overlapping ORFs were identified immediately
downstream of the ORF 1b region. A small internal open
reading frame designated ORF2b capable of encoding a
small protein of 73 amino acids was also confirmed within
the ORF2a coding region. The 3VUTR of the P129 genome
was 151 nucleotides long, identical in length to those of
VR-2332 and PA-8, and differing in sequence by 8 and 10
nucleotides, respectively (Wootton et al., 2000). The
overall nucleotide sequence identity between the P129
and VR-2332 genomes was 91.5%, while P129 and PA-8
share 91.2% identity. In contrast, VR-2332 and PA-8 are
very closely related to one another (99.3% identical). Of
the available full-length PRRSV sequences, the closest
relatives of P129 appear to be Chinese isolate CH-1a
(94.9% identity; GenBank AY032626) and US isolate
NVSL 97-7985 IA 1-4-2 (94.2% identity; GenBank
AF325691). Of these, the later is identified as an batypicalQ
PRRSV isolate. Given the genetic similarities, remarkably
high virulence, timing of field isolation (late 1995), and
geographic location (Midwest), we believe it is likely that
P129 may be related to, or even a precursor of, thebatypicalQ or bacuteQ PRRS outbreaks that occurred a year
later (late 1996 and 1997) in the Midwestern United States
(Key et al., 2001).
Construction of infectious cDNA clones
The cDNA fragments were assembled into a single clone
from four overlapping cDNA fragments (designated 1756,
8078, 2850, and 3892) using the restriction sites Bsu36I at
nucleotide position 1632, NdeI at 9399, Eco47III at 11785,
and SpeI derived from the plasmid (Fig. 1B). The 5Vend of
the genome was cloned using a double-stranded synthetic
adapter to include the PacI restriction site and the T7
promoter sequence immediately upstream of the viral
sequence (Fig. 1A). Thus, predicted transcripts from the
T7 promoter will include a single extra dGT residue derived
from the promoter sequence immediately upstream of the
first nucleotide dAT of the viral genome. The 3V most
terminus of the genome was determined by ligating the 3V
and 5Vends of the viral genome and amplifying the junction
fragment by RT-PCR. The resulting fragment contained the
complete 3Vend of genome including the polyadenosine tail.
The final construct pT7-P129 is comprised of cDNA
representing the entire genome and a 21-residue synthetic
polyadenosine tail, positioned behind the T7 promoter, and
flanked by two unique restriction sites (PacI and SwaI). To
eliminate the need for in vitro transcription and the
variability associated with transfection of mammalian cells
with RNA, the full-length genomic clone was placed under
the human cytomegalovirus (hCMV) promoter of a eukary-
otic expression vector. The full-length genomic cDNA
fragment was recovered from pT7-P129 and subcloned into
modified pCMV using PacI and SpeI (Fig. 1C). This
construct was designated pCMV-S-P129.
Infectivity of the full-length cDNA clones in cell culture
Infectivity of the full-length cDNA clone pT7-P129 was
first determined in Marc-145 cells using RNA transcripts
synthesized in vitro. Plasmid pT7-P129 was digested with
PacI and SwaI, and the full-length genomic RNA was
Fig. 1. Strategies for construction of the full-length genomic cDNA clone of PRRSV. (A) Nucleotide sequence of the region between T7 promoter and the 5V
terminus of the viral genome. Restriction sites are underlined. The T7 promoter is shown in bold face and the start of the P129 genome is indicated by the
forward arrow immediately downstream of the T7 promoter. (B). Organization of the viral genome and assembly of the full-length cDNA clone. Designation of
la, 1b, and 2 through 7 represents individual open reading frames starting from the 5Vend of the PRRSV genome. Numbers in parenthesis indicate nucleotide
positions of the P129 virus genome. Both 5Vand 3Vuntranslated regions (UTR) are indicated by solid lines. Downstream of the 3VUTR, (A21) indicates a poly(A)
tail of 21 A’s. Unique restriction sites used for assembly of fragments are indicated with their nucleotide positions in parenthesis. Four overlapping cDNA
fragments representing the entire viral genome are designated Fragments 1756, 8078, 2850, and 3892, according to their exact sizes. These fragments were
individually cloned in pCR2.1. The T7 promoter sequence was inserted upstream of the 5Vterminus of the viral genome in Fragment 1756. Fragments 1756 and
8078 were first assembled using Bsu36 and the clone was designated pT7RG. Fragment 2850 was then inserted into pT7RG using NdeI to construct pT7-
1A1B. At last, Fragment 3892 was ligated to pT7-1A1B using Eco47III to create the full-length cDNA clone pT7-P129. (C) Construction of pCMV-P129 and
nucleotide sequence of the junction between the human cytomegalovirus (CMV) immediate early promoter and the start of the viral genome. The fully
assembled P129 genomic cDNA sequence was excised from pT7-P129 and subcloned into the pCMV plasmid containing the CMV promoter using PacI and
SpeI, and named pCMV-S-P129. The TATA box from the CMV promoter is underlined in bold face, the restriction recognition sequences are underlined. The
start of the P129 genome is indicated in bold face and underlined.
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analog. The resulting transcript included a polyadenosine
tail of 21 A’s plus nine non-PRRSV nucleotides derived
from the plasmid. The in vitro transcription reaction was
added to a fresh monolayer of cells for 1 h and the
transfection mix was removed followed by further incuba-
tion of cells. At 3 days of incubation, the cytopathic effect
typical for PRRSV was observed (data not shown).Infectivity of pCMV-S-P129 was also determined. Marc-
145 cells were directly transfected with the circular plasmid
DNA of pCMV-S-P129. CPE appeared at 3 days post-
transfection and became prominent by 4 days post-trans-
fection (Fig. 2A). The specificity of CPE was confirmed by
RT-PCR and sequencing, and by immunofluorescence using
rabbit antiserum for nonstructural proteins nsp2/3 and the
N-specific MAb SDOW17. At 2 days post-transfection, the
Fig. 2. Infectivity of the full-length genomic cDNA clone. Marc-145 cells in a 35-mm diameter dish were transfected with 2 Ag of pCMV-S-P129 using
Lipofectin for 20 h. The transfection mix was removed and cells were further incubated. (A) Cytopathic effect became visible at 3 days post-transfection and
was photographed using an inverted microscope. For cell staining, transfected cells were fixed with cold methanol at 2 days post-transfection and reacted with a
rabbit antiserum specific for nsp2/3 or with MAb SDOW17 specific for N, followed by staining with the FITC-conjugated goat anti-rabbit antibody or the
Alexa green-conjugated goat anti-mouse antibody, respectively. (B) Plaque morphologies of parental P129 virus (left wells) or reconstituted virus produced by
DNA transfection of Marc-145 cells with pCMV-S-P129 (right wells). (C) Titers of the recombinant virus rP129 at different passages. The recombinant virus
was passaged three times in Marc-145 cells and titrated by plaque assay. The culture supernatant from DNA transfected cells is designated dpassage-1T. Error
bars represent standard deviations of mean values from two experiments.
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(Fig. 2A). N protein staining was also observed in the
nucleolus, confirming that the molecularly cloned virus
possessed the property of N for nuclear localization as
reported in PRRSV. The infectious cDNA clone pCMV-S-
P129 produced progeny infectious virus with indistinguish-
able plaque morphology compared to the parental P129
virus (Fig. 2B). These data demonstrate that PRRSV
infection can be initiated directly from the plasmid DNA
containing the full-length PRRSV sequence without an in
vitro transcription step.
To rule out the possibility of contamination with the
parental virus, RT-PCR and sequencing were performed for
virus recovered from DNA transfection. The reconstituted
virus derived from the full-length cDNA clone pT7-P129 or
pCMV-S-P129 still retained both T and G at genomic
nucleotide positions 1559 and 12622, respectively, con-
firming that the infectivity in transfected cells was derived
from the DNA construct, and thus both full-length cDNA
clones were indeed infectious. The two mutations had no
apparent influence on viral growth in cell culture and
consequently served as the genetic marker to distinguish the
recombinant virus from the parental virus. The sequencing
results also confirmed that the two genetic markers were
stably retained in the cloned virus (T at genomic position1559 and G at position 12622) for at least 150 passages in
Marc-145 cells (data not shown). For subsequent studies,
pCMV-S-P129 and its progeny virus were chosen for use.
The culture supernatant was collected at 5 days post-
transfection and designated dpassage-1T. The titer of
passage-1 virus was determined to be 1  103 pfu/ml
(Fig. 2C). The cloned virus was further amplified by
subsequent passages in Marc-145 cells and the titer of
dpassage-3T virus increased to 5  105 pfu/ml (Fig. 2C). The
growth kinetics of the reconstituted virus was compared to
the parental virus by one-step growth curve using the
passage-3 virus. The parental virus and the reconstituted
virus showed indistinguishable growth kinetics in Marc-145
cells and reached titers of 5  105 pfu/ml within 3 days
postinfection. The data indicate that the reconstituted virus
obtained from the full-length cDNA clone grew to the same
titer as the parental virus (data not shown).
Infectivity of recombinant virus in pigs
The pT7-P129-derived rP129 virus was examined for its
ability to infect and cause clinical disease in pigs. Three
groups of 10 pigs each were infected intranasally at 4 weeks
of age with cell culture medium (group A), 9  105 PFU per
pig with P129 parental virus (group B) or rP129 recon-
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coughing, attitude, fever, and weight gains was monitored
daily for 2 weeks postinfection. Clinical scores were
assigned to all pigs at days 1, 2, 6, 7, 8, 9, 10, and 13
postinfection based on a point scale that independently
considers attitude (0–3 points), respiratory rate (0–2 points),
respiratory distress (0–3 points), and coughing (0–1 point).
The reconstituted virus rP129 replicated well in pigs and
caused infection in the animals. By day 6 postinfection, pigs
in the two infected groups showed signs commonly
associated with PRRS, including facial or periocular edema,
lethargy, mild conjunctivitis, and respiratory signs. The
severity of clinical signs was similar in the two infected
groups. The mild clinical scores were seen in some pigs of
the noninfected control group, and these were mostly
attributable to mild lethargy and slightly increased respira-
tory rates. Rectal temperatures were determined at days 1,
0, 3, 6, 8, 10, and 13 postinfection. No significant increase
of rectal temperature was observed. Body weights were
determined at days 8, 1, 6, and 13 postinfection. All
groups showed similar average body weights throughout the
study and had normal body weights and growth for their
age. Viremia was comparable in pigs of groups B and C
(Fig. 3A), antibody responses were similar for both groupsFig. 3. Viremia (A) and serum antibodies for PRRSV (B) in pigs infected
with the recombinant virus rP129 and parental virus P129.(Fig. 3B), and there was no other significant difference
between the two virus-infected groups.
Gross and microscopic lung lesions were determined at
necropsy at day 13 postinfection. General gross necropsy
findings showed that overall, the animals were grossly
normal other than the lungs. Lungs were assigned a score
based on gray mottling (0–4 points) and edema (0–3 points).
Animals in the two infected groups showed mottling and
edema typical of PRRSV infection and had higher scores
(3.2 and 2.2 for groups B and C, respectively) than those in
the noninfected control group (0.33). To determine the
enlargement of lymph nodes, one inguinal lymph node was
weighed per pig, and a lymph node to body weight ratio was
calculated. The two infected groups had ratios that were
higher (0.174 and 0.169 for groups B and C, respectively)
than the noninfected control groups (0.073) and were similar
to each other.
Histopathological examination of lungs used a scoring
system that considers pneumonia (0–6 points) and severity
of lung lesions using six separate parameters (0–5 points
each). None of the animals showed signs of pneumonia.
Histopathological lung lesion scores in the two infected
groups were higher (37.3 and 32.5 for groups B and C,
respectively) than in the noninfected control group (1.95)
and were similar to each other. From the infection studies,
we conclude that the cDNA-derived reconstituted PRRS
virus replicates well in pigs and causes clinical disease,
quantitatively and qualitatively similar to the parental
virus.
Construction of PRRSV cysteine mutants
It has been shown that the N protein of North American
PRRSV undergoes homodimerization and that the dimeri-
zation of N is sensitive to an alkylating agent in cells but
resistant in extracellular virions. The N protein contains
three cysteines at positions 23, 75, and 90, and cysteine 23
is responsible for the disulfide-linked dimerization (Wootton
and Yoo, 2003). This was confirmed in the present study
using the three individual cysteine mutant N genes of
PRRSV PA-8 strain (N-C23S, N-C75S, N-C90S) expressed
in HeLa cells by the T7-expressing vaccinia virus (Fig. 4A).
Cell lysates were prepared in the presence of an alkylating
agent and the N protein was immunoprecipitated using a
mixture of N-specific MAbs followed by SDS-PAGE in the
absence of h-mercaptoethanol (Fig. 4B). While N-C75S and
N-C90S did not affect the dimerization of N (Fig. 4B, lanes
9 and 10), N-C23S resulted in the disruption of dimerization
and the 30-kDa protein was no longer seen in the absence of
h-mercaptoethanol (Fig. 4B, lane 8). This verifies the
involvement of cysteine 23 in the N protein dimerization
in vitro.
To investigate the functional significance of N protein
dimerization and the role of cysteines for virus infectivity,
the reverse genetics system was applied. A shuttle plasmid
was first constructed to facilitate manipulation and mod-
Fig. 4. Dimerization of PRRSV N protein and identification of a cysteine
responsible for dimerization. (A) Location of three cysteines in the 123
amino acid protein of N in North American PRRSV. Each cysteine was
mutated to serine in the pCITE-N plasmid. N-WT, wild-type N protein; N-
C23S, mutation of cysteine at position 23 to serine; N-C75S, mutation of
cysteine 75 to serine; N-C90S, mutation of cysteine 90 to serine. (B)
Radioimmunoprecipitation of cysteine mutant N proteins under reducing
(+hME) or nonreducing (hME) conditions. The cysteine mutants were
individually expressed in HeLa cells using the vTF7-3 vaccinia virus. Cells
were radiolabeled with [35S]methionine and lysed with RIPA buffer. Cell
lysates were immunoprecipitated by a mixture of N-specific MAbs and the
immune complexes were disassociated in sample buffer in the presence
(+hME) or absence (hME) of h-mercaptoethanol. Dissociated proteins
were resolved by SDS–12% PAGE and radiographic images were
visualized by a phosphorimager. Arrows indicate monomers (N) and
dimers (2N) of the N protein.
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fragment, representing nucleotide positions 11504–15500
of the viral genome and downstream plasmid sequences,
was PCR amplified and cloned into the pTrueBlue vector,
which was named pTB-shuttle-PRRSV-3997 (Fig. 5A). This
shuttle plasmid contained all of the structural genes and the
3V untranslated region plus the polyadenosine tail. The
nucleotide sequence of the shuttle plasmid was redetermined
for the PRRSV genomic portion, and the absence of
mutation was confirmed (data not shown). Using the shuttle
plasmid, PCR-based mutagenesis was conducted to sub-
stitute codons for each cysteine at positions 23, 75, and 90
of the N gene for serine codons. The mutated sequences
were rescued into the full-length genomic clone pCMV-S-
P129 by subcloning the BsrGI/SpeI fragment, which was
obtained from the shuttle plasmid. The transformants were
initially screened by restriction digestions using BsrGI and
SpeI and subsequently sequenced to confirm the specific
mutations of the N gene. As shown in Fig. 5B, individualmutations at positions 23, 75, and 90 were introduced into
the full-length cDNA clone, and the corresponding mutant
constructs were termed P129-N-C23S, P129-N-C75S, and
P129-N-C90S, respectively.
Infectivity of PRRSV N cysteine mutant genomic clones
The three independent cysteine mutant genomic clones
were individually tested for their infectivity by transfection
into PRRSV-susceptible cells. Marc-145 cells were trans-
fected with P129-WT, P129-N-C23S, P129-N-C75S, or
P129-N-C90S, and the appearance of CPE was monitored
daily. The wild-type clone P129-WT and the C75S mutant
P129-N-C75S induced visible CPEs at 3 days post-trans-
fection. When stained with N-specific MAb, many clusters
of cells showed bright fluorescence, suggesting the infection
and spread of virus to neighboring cells (Fig. 6A). In
contrast, transfection of either P129-N-C23S or P129-N-
C90S did not produce any visible CPE for up to 7 days post-
transfection, suggesting the absence of virus infectivity in
these cells. It is noteworthy, however, that a few single cells
showed N-specific fluorescence in dishes transfected with
P129-N-C23S or P129-N-C90S (Fig. 6A). These single
spots may represent individual transfected cells. Due to the
low transfection efficiency in Marc-145 cells (which are the
only permissive established cells for PRRSV infection) and
the lack of infectivity of reconstituted mutant virus, it was
not possible to show dimerization of N in cells upon
transfection with each cysteine mutant clone.
To eliminate a possibility that an additional mutation
might have been introduced in the infectious cDNA clone
during the construction of mutant clones and that the
additional mutation might have affected the viability of
mutants in transfected cells, identical cysteine mutant clones
were generated and examined for their infectivity. Eight,
three, and six different transformants were independently
obtained for P129-N-C23S, P129-N-C75S, and P129-N-
C90S, respectively, and these transformants were individu-
ally examined for their infectivity and N gene sequence. No
other mutations were identified in these parallel clones at
least for N gene, and all three P129-N-C75S mutant clones
were infectious, whereas all eight P129-N-C23S mutant
clones and all six P129-N-C90S mutant clones were
noninfectious. The two genetic markers introduced to the
infectious clone were confirmed to be retained at both
locations in all mutant constructs. The infectivity studies
using identical clones for each mutation support the
conclusion that the lack of detectable infectivity of P129-
N-C23S and P129-N-C90S was due to the mutated
cysteines.
To examine whether the absence of visible CPE in cells
transfected with P129-N-C23S or P129-N-C90S was due to
low and therefore undetectable levels of virus production, the
culture supernatants were collected from transfected cells at 7
days post-transfection and passaged three times in Marc-145
cells for infectivity amplifications. Neither CPE nor N-
Fig. 5. Shuttle vector construction (A) and generation of cysteine mutant full-length clones (B). (A) The 3997-bp fragment representing the region between
11,504 and 15,500 was PCR amplified from the full-length clone pCMV-S-P129 and cloned into pTrueBlue vector, generating pTB-shuttle-PRRSV-3997. This
shuttle plasmid is comprised of the entire structural gene region, the 3VUTR, the polyA tail, and downstream plasmid sequences. Numbers with horizontal lines
indicate size of fragments and numbers with vertical lines indicate nucleotide positions of the viral genome. (B) PCR-based site-directed mutagenesis was
performed using the shuttle plasmid pTB-shuttle-PRRSV-3997. Codons for each cysteine were changed for serine. The mutated shuttle plasmids were digested
with BsrGI and SpeI, and the resulting 2772-bp fragment was inserted into the pCMV-S-P129 full-length plasmid. The mutations were confirmed in the final
constructs by sequencing. Amino acids are presented by a single-letter code. Arrows with numbers indicate mutated amino acids at the indicated positions.
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days postinfection with the passage-3 supernatant (data not
shown), while extensive CPE and intensive N-staining were
evident in 2 days in cells infected with the passage-3 P129-
WT or P129-N-C75S viruses. To further examine a possible
infectivity of P129-N-C23S and P129-N-C90S, RT-PCR was
conducted from passage three viruses (Fig. 6B). Total RNA
was extracted from both culture media and cells infected with
the passage-3 supernatants. To avoid a possible carry-over
contamination from the transfected DNA, RNA preparations
were treated with RNase-free DNase I, and the N gene was
RT-PCR amplified. While a 400-bp product was amplified
from both culture media and cells infected with P129-WT or
P129-N-C75S (Fig. 6B, lanes 3, 5, 8, and 10), no product was
amplified from either supernatants or cells inoculated with
P129-N-C23S or P129-N-C90S (Fig. 6B, lanes 4, 6, 9, and
11). These results suggest that the C23S and C90S mutationsare lethal for virus replication, and as a consequence, no
viable virus particles were generated from cells transfected
with the mutated genomic clones. The 400-bp PCR fragments
obtained from P129-WT or P129N-C75S were sequenced,
and the sequencing results confirmed the authenticity of the
amplified product and the stable incorporation of cysteine
mutation to the viral genome for at least three passages in cell
culture.
Since it was not possible to identify any infectivity from
cells transfected with P129-N-C23S and P129-N-C90S, the
abilities of the mutant clones for genome replication and
subgenomic RNA transcription were examined. Marc-145
cells were transfected for 2 days and costained using the
Texas red-labeled rabbit antiserum specific for nsp2/3
nonstructural proteins and the Alexa green-labeled
SDOW17 MAb specific for N (Fig. 7). In cells transfected
with P129-WT and P129-N-C75S, clusters of cells were
Fig. 6. Infectivities of the cysteine mutant genomic clones (A) cytopathic effects (upper panels) and immunostaining with the N-specific MAb SDOW17 (lower
panels) in cells transfected with individual genomic clones. Marc-145 cells were transfected with 2 Ag of the genomic clone of P129-WT, P129-N-C23S, P129-
N-C75S, or P129-C90S and incubated for 3 days. CPEs were observed daily and photographed at 3 days post-transfection using an inverted microscope. For
immunostaining, transfected cells were fixed with cold methanol at 2 days post-transfection and incubated with SDOW17, followed by incubation with goat
anti-mouse secondary antibody conjugated with Alexa green. Cells were then examined using a fluorescent microscope. The intensely stained green spots
correspond to N proteins of the wild-type virus P129-WT and the cysteine 75 mutant virus P129-N-C75S. Singly stained green spots represent the cell
transfected with P129-N-C23S or P129-N-C90S genomic clones. (B) Determination of N gene by RT-PCR from cells and culture supernatants inoculated with
the passage-3 viruses. Total RNAwas extracted from culture supernatants or cells inoculated with passage-3 virus and treated with DNase I prior to RT-PCR. A
400-bp fragment corresponding to the N gene was PCR amplified and visualized in a 1% agarose gel.
C. Lee et al. / Virology 331 (2005) 47–62 55costained by both antibodies showing bright signals for
nsp2/3 (red) and N (green) proteins (Fig. 7; panels A, B, G,
and H). These data show that the N and replicase proteins
are expressed upon transfection and accumulated in the
perinuclear region and cytoplasm and the infectivity spreads
to surrounding cells. The N protein staining was also
observed in the nucleoli of transfected cells, which is a
unique feature of PRRSV N (Fig. 7A; Rowland et al., 1999).
Merging of the two images exhibited yellow regions where
the two proteins were coexpressed (Fig. 7; panels C, F, I,
and L), which are considered the replication foci. For P129-
N-C23S and P129-N-C90S, costaining of N (green) and
nsp2/3 (red) was also observed but limited to a single cell,
and no evidence was obtained for spread of the infection
(Fig. 7; panels D, E, J, and K). The single cell was assumed
to be the DNA-transfected cell, and the lack of staining in
the surrounding area is explained by the absence of released
live virus. The costaining in singly transfected cell indicates
the synthesis of both N and nsp2/3 proteins upon trans-fection. Taken together, the data indicate that both C23S and
C90S mutant clones are capable of replication and tran-
scription but cannot form infectious virions. From the
results, we conclude that mutation of cysteine at 23 or 90 of
the N protein is lethal and that the cysteine-linked N protein
dimerization is essential for PRRSV assembly. It was
unexpected that mutation of cysteine 90 was lethal for
PRRSV infectivity. The implication is that, in addition to
forming a homodimer, cysteine 90 residue of the N protein
may also interact with another structural protein, and this
interaction is also essential for PRRSV assembly (see
Discussion). It is interesting to note that the monomeric N
protein derived from the P129-N-C23S mutant, which is
unable to form a homodimer, was still localized to the
nucleolus (Fig. 7D), indicating that the N protein nuclear
localization does not require dimerization of N and is
independent from on-going infection. The N protein of the
P129-N-C90S mutant was also found to be present in the
nucleolus.
Fig. 7. Dual labeling immunofluorescence analysis of the cysteine mutant genomic clones. Marc-145 cells prepared on microscope coverslips were transfected
with 2 Ag of plasmid P129 WT, P129-N-C23S, P129-N-C75S, or P129-C90S. Cells were fixed at 2 days post-transfection and costained with N-specific MAb
SDOW17 and nsp2/3-specific rabbit antiserum, followed by staining with goat anti-mouse antibody conjugated with Alexa green or goat anti-rabbit antibody
conjugated with Texas red. Cells were observed by a laser scanning confocal microscope. N proteins are stained in green, and nsp2/3 proteins are stained in red.
Yellow regions indicate merged images, where both N and nsp2/3 are coexpressed.
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Growth characteristics of the reconstituted cysteine
mutants were determined by plaque assay in comparison
with the wild-type virus. Cells were infected with the
passage-3 virus at an moi of 5, and samples were taken fromFig. 8. Growth kinetics of mutant viruses in Marc-145 cells. Cells were
infected at an moi of 5, in duplicate, with the passage-3 preparation of
indicated viruses. Samples were taken at the indicated times and virus titers
were determined by plaque assay.culture supernatants at the indicated times. No significant
difference in growth rates was observed between P129-WT
and P129-N-C75S, and both viruses reached titers of 1 
105 by 2 days postinfection. The titers increased to a
maximum of 5  105 pfu/ml by 5 days postinfection (Fig.
8). The appearance of CPE after infection was also similar
and the plaque morphology was indistinguishable (data not
shown). These data indicate that the mutation of cysteine 75
does not affect the growth characteristics of PRRSV. As
described above, no infectious virions were found in the
culture supernatants of cells inoculated with P129-N-C23S
or P129-N-C90S (Fig. 8).Discussion
Reverse genetics is a useful tool for studying virus
replication, pathogenesis, and in vivo function of individual
viral proteins, as well as for developing viruses as vectors
and vaccines. Reverse genetics allows introduction of
changes at specific sites or regions of the viral genome in
order to create modified infectious viruses (Boyer and
Fig. 9. Presence of cysteines in the N proteins of arteriviruses. The locations
of cysteine residues in the N protein for each arterivirus are indicated by
numbers. Total number of amino acids is also indicated in numbers at the
end of each protein. PRRSN-NA, Canadian strain PA8 representing the
North American PRRSV genotype (Wootton et al., 2000); PRRSV-LV,
Lelystad virus representing the European PRRSV genotype (Meulenberg et
al., 1993); LDV, lactate dehydrogenase-elevating virus (Kuo et al., 1991);
EAV, equine arteritis virus (den Boon et al., 1991); SHFV, simian
hemorrhagic fever virus (Godeny et al., 1995). Open boxes for EAV and
SHFV represent the absence of cysteine residues.
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RNA viruses since RNA genomes are difficult to manip-
ulate directly. For PRRSV, construction of infectious cDNA
clones has previously been reported for both the European
and North American genotypes using the Lelystad and
VR2332 viruses, respectively (Meulenberg et al., 1998b;
Nielsen et al., 2003; for a review, see Yoo et al., 2004). In
both cases, the constructs are placed downstream of the T7
promoter such that the full-length genomic RNA is
synthesized in vitro and the RNA transcripts are used for
transfection of cells. In the present study, we have
constructed two versions of the infectious cDNA clone of
P129; one placed under the T7 bacterial promoter and
another placed behind the hCMV immediate early eukary-
otic promoter. Both constructs produced infectious PRRSV
with indistinguishable growth characteristics from the
parental virus and from each other. To our knowledge, this
is the first instance of an arterivirus genome being directly
transcribed successfully from a eukaryotic promoter in
mammalian cells. To assure the authenticity of the 5Vend of
the virus genome derived from the hCMV promoter, the
number of nucleotides between the TATA box and genome
start site was adjusted to 24, so that transcription by RNA
polymerase II begins at or very near the 5Vend of the viral
genome. With this bshortQ hCMV promoter system, the
plasmid DNA is used for direct transfection of PRRSV-
susceptible cells, which makes manipulation and testing of
the PRRSV genome technically easier and more consistent
than RNA transfection. Typically, the DNA-launched
system produces approximately 100 times more recombi-
nant virus than the conventional RNA-launched approach.
Upon transfection with the circular plasmid, CPE appeared
as early as 3 days post-transfection and the infectious virus
was readily recovered. The recovered virus was stable in
cell culture and could be passaged for at least 150
generations (data not shown). Reconstituted P129 virus
from the cDNA clone exhibited growth characteristics in
cell cultures and disease induction in pigs that was similar
to the parent virus.
We utilized this PRRSV infectious cDNA clone to
investigate the role of nucleocapsid cysteine residues in
viral replication and assembly. A viral capsid provides a
protective shell for the viral genome during the extrac-
ellular stage of a virus life cycle. Virions must not only be
efficiently assembled and resistant to environmental deg-
radation but also rapidly disassembled upon infection, since
they are necessarily metastable in structure. Disulfide bond
formation provides one mechanism to allow this balance by
taking advantages of intra- and extracellular oxidation
conditions (Liljas, 1999; Rietch and Beckwith, 1998).
PRRSV appears to utilize the different redox potentials
that exist in the subcellular compartments in an effort to
switch between assembly and disassembly of the virion in
the presence and absence of disulfide bonds, respectively
(Wootton and Yoo, 2003). PRRSV enters into cells via
receptor-mediated endocytosis (Nauwynck et al., 1999).Soon thereafter, the viral capsid is exposed to the reducing
environment of the cytoplasm and disassembled, probably
by destabilizing disulfide bonds so as to release the viral
genome and initiate replication and transcription. Upon
translation, the newly translated N proteins are accumulated
in the reducing condition of the cytoplasm and form
noncovalent homodimers. As the life cycle continues, the
N proteins enter the oxidizing environment of the ER or
Golgi, where PRRSV maturation and assembly take place,
and the noncovalently formed homodimers are stabilized
by disulfide linkages, which are then assembled into
nucleocapsids.
The N protein of North American PRRSV contains
three cysteines at 23, 75, and 90. These cysteines are
found in all North American isolates. Of the three, cysteine
at 23 is the one utilized for disulfide-linked homodimeri-
zation in North American PRRSV (Wootton and Yoo,
2003; Fig. 3). Cysteine residues are not well conserved
among arterivirus N proteins. The European isolates of
PRRSV contain only two cysteines at positions 27 and 76,
and the cysteine corresponding to position 90 of the North
American isolates is completely lacking (Fig. 9). The N
protein of LDV, another member of the Arteriviridae
family, contains two cysteines at positions 67, and 82,
which probably correspond to residues 75 and 90 in North
American PRRSV. However, LDV N does not possess a
cysteine corresponding to position 23 of North American
PRRSV (Fig. 9). In contrast to LDV and both genotypes of
PRRSV, the N proteins of EAV and SHFV do not possess
any of cysteines (Fig. 9), suggesting that for EAV and
SHFV, a cysteine-independent noncovalent interaction
between N proteins is sufficient for capsid formation. A
question arises then as to the biological significance of
cysteine-linked dimerization of N for PRRSV in vivo. To
address this question, the reverse genetics system was
applied. Using the infectious clone, the cysteine residues
were individually substituted to serines, and three inde-
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Despite the fact that cysteine 75 is conserved between
LDV and both genotypes of PRRSV (Fig. 9), substitution
of cysteine 75 to serine had no effect on viral infectivity.
In contrast, mutation of cysteine 23 or 90 to serine
completely blocked virus production. No evidence for
infectivity was seen in transfected cells or after three blind
passages on PRRSV-susceptible cells. Since cysteine 23 is
responsible for disulfide-linked homodimerization of N, it
is apparent that the cysteine 23-mediated N protein
homodimerization is an absolute requirement for virus
infectivity of North American PRRSV. The potential roles
of cysteine residues in N protein homodimer formation in
European PRRSV and LDV are not currently known.
It is remarkable that a single mutation at cysteine 90 also
appears to be lethal. This is an unexpected observation since
cysteine 90 is irrelevant to the N protein homodimerization
and because cysteine 90 is not conserved among the
European PRRSV isolates (Figs. 4B and 9). The P129-N-
C90S-transfected cells are able to synthesize both nsp2/3
nonstructural proteins and N protein, but the transfected
cells fail to produce any infectious virus. These findings
suggest that genomic RNA is transcribed off the transfected
DNA clone within the cell, and the viral genome is
translated to produce replicase proteins. Subgenomic
mRNAs are also transcribed from the replicating genome
and are translated to produce viral structural proteins,
suggesting an interruption during particle assembly or
virion maturation. This observation leads to a new
hypothesis that the N protein of North American PRRSV
may interact with another viral protein to form a hetero-
dimer. Although it is possible that cysteine 90 may form an
intramolecular disulfide bridge in N, this is unlikely since
other cysteines at 23 and 75 do not seem to participate in
intramolecular interactions. This is shown by the fact that
the mutation of cysteine 75 was fully viable, and cysteine 23
was involved in intermolecular interactions (homodimer
formation).
Besides the N protein, six other viral proteins comprise the
PRRS virion; GP2a, E (2b), GP3, GP4, GP5, and the M
protein. These proteins are all believed to be membrane
associated. Among those, GP5 and M are known to form
disulfide-linked heterodimers, constituting the basic matrix
of the viral envelope (Mardassi et al., 1996). GP5-M
heterodimerization has been reported to be essential for virus
infectivity for LDV and EAV, respectively (Faaberg et al.,
1995; Snijder et al., 2003). For LDV, virus infectivity was
inhibited by a reducing agent that disrupts the GP5-M
linkages. Independently, a recent study with EAV indicates
that E (GP2a in EAV is a GP2b homolog in PRRSVand both
are called E protein), GP3, and GP4 exist as disulfide-linked
heterotrimers in mature virions (Wieringa et al., 2003a,
2003b) and shows that the intermolecular disulfide linkages
of the heterotrimers are essential for virus infectivity
(Wieringa et al., 2003b). While it remains to be determined
whether heterotrimeric complexes of GP2a-GP3-GP4 arealso formed for PRRSV, GP4 has been shown to be
coprecipitated with GP3 in the case of North American
PRRSV (Mardassi et al., 1998), implicating a possible
existence of GP3 as a heteromultimer with GP4. E protein
is a newly identified structural protein for arteriviruses
(Snijder et al., 1999; Wu et al., 2001). For PRRSV, E is a
small nonglycosylated protein of 73 amino acids encoded
within ORF2a and is found in both European and North
American PRRSV. While its function remains to be
determined, it is noteworthy that the E protein of North
American PRRSV contains two cysteine residues at positions
49 and 54. Interestingly, cysteine residues are not also
conserved in the E proteins among arteriviruses since the E
proteins of LDV and European PRRSV possess only one
cysteine at amino acid position 49 or 54, respectively.
Considering that GP2a, GP3, GP4, GP5, and M may all be
associated from one another forming heterodimers or hetero-
trimers, N and E are the proteins that have not been
characterized for association with other proteins. The recent
X-ray crystallographic study of PRRSVN suggests a possible
association of N with a membrane protein in the lipid bilayer
(Doan and Dokland, 2003). Thus, it may be that N forms a
heterodimer with one of the viral membrane proteins via an
interaction between C90 of N. In this scenario, N protein
heterodimerization will favor a specific selection of viral
proteins during particle assembly to form a stable virion
structure, which is an essential requirement for PRRSV
infectivity. Studies are in progress to determine a possible
association of N with other viral protein in North American
PRRSVand the role of N for virus assembly in arteriviruses in
general.Materials and methods
Cells, viruses, and antibodies
HeLa and Marc-145 cells (a subclone of MA104 cells;
Kim et al., 1993) were grown in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 8% fetal bovine serum
(FBS; Gibco BRL), penicillin (100 U/ml), and streptomycin
(50 Ag/ml). Cells were maintained at 37 8Cwith 5%CO2. The
construction of an infectious cDNA clone was based on the
P129 strain of PRRSV. P129 is a virulent strain of PRRSV
isolated in 1995 from an outbreak of highly virulent PRRS in
Southern Indiana, USA. The farm had no previous history of
PRRS clinical disease or PRRSV vaccination. The P129 virus
produced severe and consistent respiratory disease in pigs
and was considered more virulent than other field isolates
obtained from the same time period and geographic area. The
virus was initially isolated on primary porcine alveolar
macrophages (PAM) and subsequently passaged on Marc-
145 cells. The virus was plaque purified twice, and the
purified virus was expanded to produce a large stock. The
virus stock prepared from the 10th passage in cell culture was
used for full-length genomic cDNA construction.
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Fuerst et al., 1986) were prepared in Marc-145 or HeLa
cells. Reconstituted PRRSV stocks derived from infectious
cDNA clones were prepared after three passages in Marc-
145 cells. Titers of the passages-3 viruses were determined
by plaque assays. Plaque assays were carried out in
duplicate in Marc-145 cells using 35-mm diameter dishes.
Virus-infected cell monolayers were overlayed with 0.8%
agarose in DMEM and incubated at 37 8C. At 5 days
postinfection, plaques were stained with 0.1% neutral red
and plaque numbers were determined. Monoclonal anti-
bodies (MAbs) specific for N are described elsewhere
(Nelson et al., 1993; Wootton et al., 1998). The mono-
specific polyclonal rabbit antiserum raised against non-
structural proteins 2 and 3 (nsp2/3) was kindly provided
by Eric Snijder (Leiden University Medical Center, Leiden,
The Netherlands). E. coli strains XL1-Blue (Stratagene)
and DH5a were used as hosts for site-directed mutagenesis
and for general cloning purpose, respectively.
Cloning and sequencing of the PRRSV full-length genome
The 5Vend of the viral genome was determined using 5V
rapid amplification of cDNA ends (RACE; Invitrogen)
according to instructions of the manufacturer. First-strand
cDNA was synthesized from virion RNA using the RACE2
Rev primer (Table 1). The RNA template was removed by
digestion with RNase H and RNase T1, and the first-strand
cDNA product was dC tailed using terminal deoxynucleo-
tidyl transferase. The 5V terminal fragment of the genome
representing positions 1–1756 was PCR amplified using
the dC-tailed cDNA as template and the Abridged Anchor
Primer (5V-GGCCACGCGTCGACTAGTACGGGIIGG-
GIIGGGIIG-3V) and the RACE3 Rev primer (Table 1).
The 3Vend of the viral genome was determined as follows.
Viral RNA from purified virions was treated with tobacco
acid pyrophosphatase (Epicentre Technologies) to remove
the 5V-cap structure and the 3Vand 5Vends of the viral RNA
were self-ligated with T4 RNA ligase (Epicentre Technol-
ogies). The junction region was amplified by RT-PCR
using a forward primer (5V-CGCGTCACAGCATCACCCT-
CAG-3V, positions 15218–15239) and either of two reverse
primers (5V-CGGTAGGTTGGTTAACACATGAGTT-3V,
positions 656–680 or 5V-TGGCTCTTCGGGCCTA-
TAAAATA-3V, positions 337–359). The PCR products were
gel purified, cloned into pCR2.1, and sequenced. For the
remainder of the genome, various PCR primers were
chosen based on partial cDNA sequences of other North
American PRRS virus isolates available in GenBank, while
large stretches of unknown sequence were amplified by
long RT-PCR using known sequences to anchor the ends.
Purified viral RNA was reverse transcribed into cDNA
using reverse transcriptase and random hexamer primers.
This cDNA was then used in PCR with gene-specific
primers. PCR products were excised from gels and T/A
cloned into plasmid pCR2.1 (Invitrogen). General proce-dures for DNA manipulation and cloning were performed
according to standard procedures (Sambrook and Russell,
2001). For each primer pair, multiple plasmids (from
independent PCR reactions) were sequenced. Sequences
were assembled into contigs using the Seqman program
from the Lasergene package (DNASTAR, Inc.). This
allowed us to complete the sequence of the P129 genome.
The complete genomic sequence of the P129 virus was
deposited to the GenBank database under accession
number AF494042.
Assembly of full-length cDNA clone
Four overlapping cDNA clones inserted in the pCR2.1
plasmid were assembled into a single clone using available
restriction sites in the fragments and the SpeI site in the
vector (Fig. 1B). The 5Vterminal 1756 fragment of the viral
genome was first modified to include a T7 promoter and a
PacI unique enzyme site for future cloning. For this, a
three-point ligation was performed using the 1216-bp
DsaI–BseRI fragment representing nucleotide positions
27–1242 of the genome, the 4407-bp BseRI–XbaI frag-
ment representing 1243–1756 of the genome plus the
pCR2.1 plasmid fragment to the XbaI site, and the
synthetic double-stranded adapter (Fig. 1A). The modified
5V end fragment in pCR2.1 vector was digested with
Bsu36I and SpeI, and subsequently ligated with the 7873-
bp Bsu36I–SpeI fragment from fragment 8078, resulting in
plasmid pT7RG that contains the first 9438 bp of the
genome behind the T7 promoter (Fig. 1B). The 2682-bp
NdeI–SpeI fragment from the 2850-bp fragment was
ligated to the 13249-bp NdeI–SpeI fragment of pT7RG
to yield the plasmid pT7-1A1B. Finally, to add the
structural genes to the rest of the genome, the fourth
fragment of 3892, containing ORFs 2 through 7, a 3VUTR,
and a portion of the poly(A) tail, was digested with
Eco47III and SpeI. The 3678-bp Eco47III–SpeI fragment
from fragment 3892 was ligated to the 15 635-bp
Eco47III–SpeI fragment of pT7-1A1B, generating the
full-length construct pT7-P129 (Fig. 1B).
To facilitate transfection procedures, a DNA-launched
infectious clone was constructed. The fully assembled
P129 genomic cDNA clone was subcloned into the
eukaryotic expression vector pCMV, derived from the
plasmid pCMV-h (Clontech), which contains the human
cytomegalovirus (hCMV) immediate early promoter. The
region between the TATA box and the PacI site was
modified so that, in the final construct, the transcriptional
start site would correspond closely with the first base of
the PRRSV genome. The sequence immediately upstream
of the 5Vend of the P129 genome was modified to contain
proper spacing and a convenient restriction enzyme site
(PacI). This was done by designing appropriate PCR
primers for amplification from pT7P129. After digestion
with PacI and AatII, this PCR fragment was subcloned
into the PacI and AatII sites of pT7RG. The resulting
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genomic cDNA was digested from pT7-P129-deltaT7 at
the PacI and SpeI sites and transferred into the modified
pCMV at the same enzyme sites, generating the plasmid
pCMV-S-P129 (Fig. 1C).
Shuttle plasmid construction, site-directed mutagenesis, and
generation of mutant full-length PRRSV cDNA clones
To introduce specific modifications to the full-length
genomic clone, a shuttle plasmid was constructed. The 3V
most 3997-bp fragment, representing nucleotide positions
11504–15500 of the viral genome (including the 3VUTR
and the tail of 21 A’s) and 84 bp of downstream vector
sequences, was amplified by PCR using the P-shuttle-Fwd
(5V-ACTCAGTCTAAGTGCTGGAAAGTTATG-3V) and P-
shuttle-Rev primers (5V-ATCTTATCATGTCTGGAT-
CCCCGCGGC-3V). The PCR product was cloned into the
pTrueBlue vector using the TrueBlue MicroCartridgek
PCR Cloning Kit XL (Genomics One; Buffalo, NY) to
create pTB-shuttle-PRRSV-3997. Site-directed mutagenesis
to substitute cysteine of N to serine was conducted using
the shuttle plasmid and the following primer pairs: for
C23S mutation, C23S-Fwd (5V-GTCAATCAGCTGAGC-
CAGATGCTG-3V) and C23S-Rev (5V- CAGCATCT-
GGCTCAGCTGATTGAC-3V); for C75S mutation, C75S-
Fwd (5V-GCGGCAATTGAGTCTGTCGTCAATC-3V) and
C75S-Rev (5V-GATTGACGACAGACTCAATTGCCGC-3V);
for C90S mutation, C90S-Fwd (5V-CGCTGGGACTAG-
CACCCTGTCAG-3 V) and C90S-Rev (5 V-CTGA-
CAGGGTGCTAGTCCCAGCG-3V), where underlined
letters indicate mutated nucleotides. PCR-based mutagen-
esis and screening of mutants were performed as described
previously (Wootton et al., 2001). The cDNA cloning of
the N gene from the PRRSV strain PA-8 and generation of
pCITE-N are described elsewhere (Wootton et al., 1998).
Shuttle plasmids carrying the cysteine mutation were
digested with BsrGI and SpeI, and a 2772-bp fragment was
purified. The wild-type full-length genomic clone was
digested with BsrGI and SpeI, and the 2772-bp BsrGI–
SpeI fragment was replaced with the corresponding frag-
ment obtained from the shuttle plasmid. For every construct,
substitution of cysteine to serine was verified by nucleotide
sequencing.
Protein expression, radiolabeling, and immunoprecipitation
The PRRSV N protein and its mutant derivatives were
expressed in HeLa cells using the T7-based vaccinia
virus vTF7-3. HeLa cells grown to 90% confluency were
infected for 1 h at 37 8C with vTF7-3 at an moi of 10.
Following infection, fresh medium was added and
incubation continued for an additional 1 h. The cells
were washed twice in OPTI-MEM (Invitrogen) and
transfected with 1.5 Ag of plasmids for 16 h using
Lipofectin (Invitrogen) according to the manufacturer’sinstruction. For radiolabeling, the transfected cells were
starved for 30 min in methionine-deficient MEM (Invi-
trogen) and incubated for 5 h with 100 ACi/ml of
EasyTag EXPRESS protein labeling mix ([35S]methionine
and [35S]cysteine, specific activity, 407 MBq/ml) (Perkin-
Elmer). At the end of the labeling period, cells were
harvested, washed twice and cold PBS, and lysed with
RIPA buffer (1% Triton X-100, 1% sodium deoxycholate,
150 mM NaCl, 50 mM Tris–HCl [pH 7.4], 10 mM
EDTA, 0.1% SDS) containing 1 mM phenylmethylsul-
fonyl fluoride (PMSF) and 20 mM N-ethylmaleimide
(NEM) (Fisher). After incubation on ice for 20 min, the
cell lysates were centrifuged at 14,000 rpm for 30 min in
a microcentrifuge (model 5415; Eppendorf), and super-
natants were recovered.
For immunoprecipitation, cell lysates equivalent to 1/15
of a 100-mm diameter dish were adjusted with RIPA buffer
to a final volume of 100 Al and incubated for 2 h at room
temperature with 1 Al of a mixture of N-specific MAbs. The
immune complexes were adsorbed to 7 mg of protein-A
Sepharose CL-4B beads (Amersham Biosciences) for 16 h
at 4 8C. The beads were collected by centrifugation at 6000
rpm for 5 min and washed twice with RIPA buffer and once
with wash buffer (50 mM Tris–HCl [pH 7.4], 150 mM
NaCl). The beads were resuspended in 20 Al of SDS-PAGE
sample buffer (10 mM Tris–HCl [pH 6.8], 25% glycerol,
10% SDS, 0.12% [wt/vol] bromophenol blue) with or
without 10% h-mercaptoethanol (hME), boiled for 5 min,
and analyzed by 12% SDS polyacrylamide gel electro-
phoresis (PAGE). Gels were dried on filter paper and
radiographic images were obtained using a phosphorimager
(model PhosphorImager SI; Molecular Dynamics).
Immunofluorescence
Marc-145 cells were seeded on microscope coverslips
in 35-mm diameter dishes and grown overnight to a
confluence of 70%. The cells were transfected with 2 Ag of
plasmid DNA using Lipofectin according to the manufac-
turer’s instruction (Invitrogen). At 48 h post-transfection,
cell monolayers were washed twice in PBS and fixed
immediately with cold methanol for 10 min. For immuno-
fluorescence, cells on microscope coverslips were blocked
using 1% BSA in PBS for 30 min at room temperature.
The cells were then incubated with the nsp2/3-specific
rabbit antiserum or N-specific MAb SDOW17 for 2 h.
After washing five times in PBS, the cells were incubated
for 1 h at room temperature with fluorescein isothiocyanate
(FITC)-labeled goat anti-rabbit secondary antibody (KPL)
or with goat anti-mouse secondary antibody conjugated
with Alexa green dye (Molecular Probes). For dual
immunofluorescence, cells were costained with nsp2/3-
specific rabbit antiserum and N-specific MAb SDOW17,
followed by staining with goat anti-rabbit antibody
conjugated with Texas red (Molecular Probes) and goat
anti-mouse antibody conjugated with Alexa green. The
C. Lee et al. / Virology 331 (2005) 47–62 61coverslips were washed five times in PBS and mounted on
microscope glass slides in mounting buffer (60% glycerol
and 0.1% sodium azide in PBS). Cell staining was
visualized using a laser confocal scanning microscope
(model TCS SP2; Leica Microsystems GmbH, Heidelberg,
Germany).
Production of infectious virus from full-length cDNA clones
Marc-145 cells were seeded in 35-mm diameter dishes
and grown to 70% confluency. The cells were transfected
for 24 h with 2 Ag of the full-length cDNA plasmid using
Lipofectin. The transfected cells were continued for
incubation at 37 8C in DMEM supplemented with 8%
FBS for 5 days. The culture supernatants were harvested at
5 days post-transfection and designated dpassage-1T. The
passage-1 virus was used to inoculate fresh Marc-145 cells
and the 5-day harvest was designated dpassage-2T. The
dpassage-3T virus was prepared in the same way as for
passage-2. Each passage virus was aliquoted and stored at
80 8C until use.
RT-PCR for N gene mutants and sequencing
Viral RNA was extracted from either supernatants or
lysates of infected cells using the QiaAmp viral RNA mini
kit (Qiagen). To remove any contaminated DNA in the
RNA preparations, samples were treated with 1 unit of RQ
DNase I (Promega) at 37 8C for 30 min in 50 mM Tris–
HCl [pH 7.5] and 1 mM MgCl2. First-strand cDNA
synthesis was performed by Moloney Murine Leukemia
Virus (M-MLV) reverse transcriptase (Invitrogen) using the
reverse primer ORF7-Rev (5V-AGAATGCCAGCCCATCA-
3V). The N gene was amplified by Taq DNA polymerase
(Invitrogen) using ORF7-Fwd (5V-CCTTGTCAAATATGC-
CAA-3V) and ORF7-Rev under the following conditions;
initial denaturation at 95 8C for 5 min, 35 cycles of:
denaturation at 95 8C for 30 s, annealing at 56 8C for 30 s,
and extension at 72 8C for 1 min, followed by a final
extension at 72 8C for 7 min. PCR products were analyzed
by 1% agarose gel electrophoresis. Amplified products
were purified using the PCR purification kit (Qiagen) and
sequenced.
Experimental infection of pigs
Thirty piglets of 4 weeks age were obtained from a
PRRSV-free herd. Piglets were acclimatized for 3 days in
the isolation facility before infection with the virus. Animals
were divided to three groups of 10, and animals within the
same group were housed in the same room. Animals were
infected with either P129 parental virus, cDNA-derived
recombinant virus rP129, or cell culture medium at a virus
concentration of 4.5  104 pfu/ml in 2-ml volume by
inoculation of 1 ml per nostril. Clinical signs (coughing,
sneezing, appetite, and behavior), rectal temperatures andbody weights were examined daily for 2 weeks. Blood
samples were taken on days 0, 2, 6, 10, and 13 post-
infection. Serum viremia was determined by plaque assay,
while induction of antibody was determined by ELISA
using a commercial antibody detection kit (HerdCheck
PRRS; IDEXX, Westbrook, ME). Gross pathology of lungs
was determined at necropsy.Acknowledgments
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